The Seoul Central District Court said in a
statement it had granted warrants to arrest the executives due
to concerns over possible destruction of evidence.
However, the court rejected the prosecution's request for a
warrant to arrest the chief executive of Samsung BioLogics Co
Ltd.
Two Samsung Electronics officials were also arrested on
suspicion of destroying evidence earlier this month.
South Korea's financial watchdog in November accused the biotech
arm of Samsung Group of breaking accounting rules ahead of its
2016 listing, sparking a criminal investigation.
Both Samsung Electronics and Samsung BioLogics were not
immediately available for comment.
The widening probe comes at an awkward time for Samsung Group,
South Korea's top family-run conglomerate, as de facto head and
heir Jay Y.Lee awaits a Supreme Court ruling on bribery charges
and political pressure builds for greater transparency in its
governance.
Samsung BioLogics had been touted as a new growth engine for
Samsung Group amid a slowdown in the global smartphone market.
Samsung Electronics is the second-biggest shareholder of
BioLogics with a 31.5 percent stake.
Samsung Electronics had no comment on the case earlier, except
that it was cooperating with prosecutors.
(Reporting by Heekyong Yang; Editing by Stephen Coates and Elane
Hardcastle)
[© 2019 Thomson Reuters. All rights
reserved.] Copyright 2019 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|